Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus
Open Access
- 1 October 2009
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 17 (10), 1814-1821
- https://doi.org/10.1038/mt.2009.154
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- The p14 FAST Protein of Reptilian Reovirus Increases Vesicular Stomatitis Virus NeuropathogenesisJournal of Virology, 2009
- Vesicular Stomatitis Virus-Based Therapeutic Vaccination Targeted to the E1, E2, E6, and E7 Proteins of Cottontail Rabbit PapillomavirusJournal of Virology, 2007
- Killer T cells regulate antigen presentation for early expansion of memory, but not naive, CD8+T cellProceedings of the National Academy of Sciences, 2007
- Oncolytic Vesicular Stomatitis Virus Induces Apoptosis via Signaling through PKR, Fas, and DaxxJournal of Virology, 2007
- Evaluation of Prime/Boost Regimens Using Recombinant Poxvirus/Tyrosinase Vaccines for the Treatment of Patients with Metastatic MelanomaClinical Cancer Research, 2006
- Immunogenicity of Attenuated Vesicular Stomatitis Virus Vectors Expressing HIV Type 1 Env and SIV Gag Proteins: Comparison of Intranasal and Intramuscular Vaccination RoutesAIDS Research and Human Retroviruses, 2004
- Vesicular stomatitis virus: re-inventing the bulletTrends in Molecular Medicine, 2004
- Intranasal Vaccination with a Recombinant Vesicular Stomatitis Virus Expressing Cottontail Rabbit Papillomavirus L1 Protein Provides Complete Protection against Papillomavirus-Induced DiseaseJournal of Virology, 2002
- Genetically Engineered Vesicular Stomatitis Virus in Gene Therapy: Application for Treatment of Malignant DiseaseJournal of Virology, 2002
- Perforin-independent regulation of dendritic cell homeostasis by CD8+ T cellsin vivo: implications for adaptive immunotherapyEuropean Journal of Immunology, 2001